Trial Profile
A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Danazol (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 16 Dec 2013 New trial record